Original Article

CME Article: Association of Hypertension and Hyperthyroidism in a Subspecialty Clinic and a National Database

Authors: Ana M. Rivas, MD, Jeff Dennis, PhD, Camilo Pena, MD, Jonathan Kopel, BS, Kenneth Nugent, MD

Abstract

Objective: Hypertension can cause significant morbidity and reduced life expectancy. Most patients with hypertension have primary hypertension; however, 10% to 15% have secondary hypertension. Endocrine disorders as a secondary cause occur in approximately 10% of patients with secondary hypertension, and thyroid disorders account for approximately 1% of all patients with hypertension. The identification of patients with hyperthyroidism has important benefits for these particular patients. The objective of this study was to examine the occurrence of high blood pressure in patients with hyperthyroidism.

Methods: We reviewed the clinical information available from 414 new patients referred to an endocrinology clinic in west Texas for evaluation of hyperthyroidism. The final cohort included 96 patients who had both thyroid laboratory tests and blood pressure measurements at the time of their clinic visit. We also examined this relationship in a nationally representative sample of US adults (National Health and Nutrition Examination Survey 2007–2012), which included thyroid test results and at least one blood pressure measurement (N = 8837).

Results: Sixty-five of these clinic patients had elevated blood pressure based on criteria suggested by the American College of Cardiology/American Heart Association. These patients had similar thyroid hormone levels as patients who did not have hypertension but tended to be older. Ordinary least squares regression analysis of the National Health and Nutrition Examination Survey 2007–2012 data demonstrated a significant positive association between free T3 levels and systolic blood pressure, adjusting for age, sex, and the use of levothyroxine.

Conclusions: These findings from a specialty clinic and a national sample suggest that clinicians should consider the possibility of hyperthyroidism in patients with hypertension, even in older patients.
Posted in: Endocrinology, Diabetes, and Metabolism27 Hypertension6

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Berta E, Lengyel I, Halmi S, et al. Hypertension in thyroid disorders. Front Endocrinol 2019;DOI: 10.3389/fendo.2019.00482. 2. Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2018;138:e484–e594. 3. Whelton PK. The elusiveness of population-wide high blood pressure control. Annu Rev Public Health 2015;36:109–130. 4. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–1252. 5. O’Shea PM, Griffin TP, Fitzgibbon M. Hypertension: the role of biochemistry in the diagnosis and management. Clin Chim Acta 2017;465:131–143. 6. Young WF Jr, Calhoun DA, Lenders JWM, et al. Screening for endocrine hypertension: an Endocrine Society Scientific Statement. Endocr Rev 2017;38:103–122. 7. Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens (Greenwich) 2006;8:596–599. 8. Marcisz C, Jonderko G, Kucharz E. Changes in arterial pressure in patients with hyperthyroidism during therapy. Med Sci Monit 2002;CR502–507. 9. Iglesias P, Acosta M, Sanchez R, et al. Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function. Clin Endocrinol (Oxf.) 2005;63:66–72. 10. Papaleontiou M, Haymart MR. Approach to and treatment of thyroid disorders in the elderly. Med Clin North Am 2012;96:297–310. 11. Rivas AM, Larumbe E, Thavaraputta S, et al. Unfavorable socioeconomic factors underlie high rates of hospitalization for complicated thyrotoxicosis in some regions of the United States. Thyroid 2019;29:27–35. 12. James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults. JAMA 2014;311:507. 13. Centers for Disease Control and Prevention. 2013;2(160). National Health and Nutrition Examination Survey: Sample Design, 2007–2010. https://www.cdc.gov/nchs/data/series/sr_02/sr02_160.pdf. Published August 2013. Accessed October 11, 2020. 14. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Laboratory Procedure Manual 2007-08, Thyroid Stimulating Hormone. https://wwwn.cdc.gov/nchs/data/nhanes/2007-2008/labmethods/thyrod_e_met_thyroid_stimulating_hormone.pdf. Published 2009. Accessed October 11, 2020. 15. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Laboratory Procedure Manual 2011-12, Thyroid Stimulating Hormone. https://wwwn.cdc.gov/nchs/data/nhanes/2011-2012/labmethods/thyrod_g_met_tsh.pdf. Published 2014. Accessed October 11, 2020. 16. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Laboratory Procedure Manual 2011-12, Free Thyroxine, Free T4. https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.644.2851&rep=rep1&type=pdf. Published 2009. Accessed October 11, 2020. 17. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Laboratory Procedure Manual 2007-08, Free Triiodothyronine, Free T3. https://wwwn.cdc.gov/nchs/data/nhanes/2007-2008/labmethods/thyrod_e_met_free_triiodothyronine_free_t3.pdf. Published 2009. Accessed October 11, 2020. 18. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913. 19. Saito I, Ito K, Saruta T. The effect of age on blood pressure in hyperthyroidism. J Am Geriatrics Soc 1985;33:19–22. 20. Hurxthal L. Blood pressure before and after operation for hyperthyroidism. Arch Intern Med 1931:167–181. 21. De la Sierra A, Vinyoles E, Banegas JR, et al. Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients. J Hypertens 2017;35:2388–2394. 22. LeFevre ML. Screening for thyroid dysfunction: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2015;162:641–650.